login

Home > Organizations > Departments and Divisions > School of Medicine Clinical Sciences Departments and Divisions > Department of Medicine Divisions > Division of Hematology and Medical Oncology > Search Results

Division of Hematology and Medical Oncology

Search:

Search Tips :: Advanced Search

Sort by

ascending
descending

Display

Collections

Select collection Select collection

Format

Select output format

1.	PDF ResearchWeek.2024.Chandra.Daniel Upregulation of HLA-e drives defective natural killer cell targeting in venetoclax-resistant acute myeloid leukemia Chandra, Daniel ; Burns, Faith ; Kosaka, Yoko ; Kurtz, Stephen E.[...] Acute myeloid leukemia (AML) is the most common leukemia in adults and is primarily diagnosed in older patients. The combination of the BCL2 inhibitor, venetoclax, with a [...] 2024 \| Abstract \| Detailed record - Similar records
2.	PDF ResearchWeek.2023.Gutierrez.Anthony Overall survival in myelofibrosis treated with allogeneic hematopoietic cell transplant is impacted by reversal of marrow fibrosis: a single inst[...] Gutierrez, Anthony ; Gandhi, Arpita ; Kaempf, Andy ; Saultz, Jennifer N.[...] Allogeneic hematopoietic cell transplantation (allo HCT) is the only curative therapy for patients with intermediate-2 or high risk myelofibrosis (MF). We sought to exami [...] 2023-07-19 \| Abstract \| Detailed record - Similar records
3.	PDF ResearchWeek.2020.UlucKutluay Safety of intra-arterial (IA) chemotherapy and blood brain barrier disruption (BBBD) for treatment of patients with malignant brain tumors Tabb, John ; Ambady, Prakash ; Neuwelt, Edward ; Uluc, Kutluay Administration of chemotherapy via intra-arterial (IA) route results in a higher concentration of targeted chemotherapy against resilient brain malignancies with a decrea [...] 2020 \| Abstract \| Detailed record - Similar records
4.	PDF Sven-Olson The role of iron repletion in adult iron deficiency anemia and other diseases Olson, Sven ; Khan, Lubna ; Elstrott, Benjamin ; Shatzel, Joseph[...] Iron deficiency anemia (IDA) is the most prevalent and treatable form of anemia worldwide. The clinical management of patients with IDA requires a comprehensive understan [...] 2020 \| Abstract \| Detailed record - Similar records

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.